当前位置: 首页 >> 检索结果
3221. Interinstitutional variation in management decisions for treatment of 4 common types of cancer: A multi-institutional cohort study.
作者: Jane C Weeks.;Hajime Uno.;Nathan Taback.;Gladys Ting.;Angel Cronin.;Thomas A D'Amico.;Jonathan W Friedberg.;Deborah Schrag.
来源: Ann Intern Med. 2014年161卷1期20-30页
When clinical practice is governed by evidence-based guidelines and there is consensus about their validity, practice variation should be minimal. For areas in which evidence gaps exist, greater variation is expected.
3222. Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data.
作者: Katie R Mollan.;Marlene Smurzynski.;Joseph J Eron.;Eric S Daar.;Thomas B Campbell.;Paul E Sax.;Roy M Gulick.;Lumine Na.;Lauren O'Keefe.;Kevin R Robertson.;Camlin Tierney.
来源: Ann Intern Med. 2014年161卷1期1-10页
The relationship between efavirenz use and suicidality is not well-defined.
3223. Screening for abdominal aortic aneurysm: U.S. Preventive Services Task Force recommendation statement.
Update of the 2005 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for abdominal aortic aneurysm (AAA).
3226. Stroke prevention in women: synopsis of the 2014 American Heart Association/American Stroke Association guideline.
In February 2014, the American Heart Association/American Stroke Association released their first guideline focused on stroke prevention in women. This new guideline highlights unique risk factors for stroke in women, including oral contraception and hormone therapy, and pregnancy-associated disorders, such as preeclampsia, that may have long-lasting consequences on a woman's health. It also addresses hypertension; atrial fibrillation; migraine headache with aura; and the epidemiology of types of stroke, such as aneurysmal subarachnoid hemorrhage and cerebral vein thrombosis, that are predominant in women.
3228. Screening for hepatocellular carcinoma in chronic liver disease: a systematic review.
作者: Devan Kansagara.;Joel Papak.;Amirala S Pasha.;Maya O'Neil.;Michele Freeman.;Rose Relevo.;Ana Quiñones.;Makalapua Motu'apuaka.;Janice H Jou.
来源: Ann Intern Med. 2014年161卷4期261-9页
Guidelines recommend routine screening for hepatocellular carcinoma (HCC) in high-risk patients, but the strength of evidence supporting these recommendations is unclear.
3229. Rate- and rhythm-control therapies in patients with atrial fibrillation: a systematic review.
作者: Sana M Al-Khatib.;Nancy M Allen LaPointe.;Ranee Chatterjee.;Matthew J Crowley.;Matthew E Dupre.;David F Kong.;Renato D Lopes.;Thomas J Povsic.;Shveta S Raju.;Bimal Shah.;Andrzej S Kosinski.;Amanda J McBroom.;Gillian D Sanders.
来源: Ann Intern Med. 2014年160卷11期760-73页
The comparative effectiveness of treatments for atrial fibrillation (AF) is uncertain.
3230. Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysis.
作者: Frank van Hees.;J Dik F Habbema.;Reinier G Meester.;Iris Lansdorp-Vogelaar.;Marjolein van Ballegooijen.;Ann G Zauber.
来源: Ann Intern Med. 2014年160卷11期750-9页
The U.S. Preventive Services Task Force recommends against routine screening for colorectal cancer (CRC) in adequately screened persons older than 75 years but does not address the appropriateness of screening in elderly persons without previous screening.
3231. Screening for hepatitis B virus infection in nonpregnant adolescents and adults: U.S. Preventive Services Task Force recommendation statement.
Update of the 2004 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for hepatitis B virus (HBV) infection.
3234. What are cancer centers advertising to the public?: a content analysis.
作者: Laura B Vater.;Julie M Donohue.;Robert Arnold.;Douglas B White.;Edward Chu.;Yael Schenker.
来源: Ann Intern Med. 2014年160卷12期813-20页
Although critics have expressed concerns about cancer center advertising, analyses of the content of these advertisements are lacking.
3235. Transitional care interventions to prevent readmissions for persons with heart failure: a systematic review and meta-analysis.
作者: Cynthia Feltner.;Christine D Jones.;Crystal W Cené.;Zhi-Jie Zheng.;Carla A Sueta.;Emmanuel J L Coker-Schwimmer.;Marina Arvanitis.;Kathleen N Lohr.;Jennifer C Middleton.;Daniel E Jonas.
来源: Ann Intern Med. 2014年160卷11期774-84页
Nearly 25% of patients hospitalized with heart failure (HF) are readmitted within 30 days.
3236. Prevention of vertical transmission of hepatitis B: an observational study.
作者: Ai Kubo.;Lyle Shlager.;Amy R Marks.;Dena Lakritz.;Colette Beaumont.;Kim Gabellini.;Douglas A Corley.
来源: Ann Intern Med. 2014年160卷12期828-35页
For mothers with chronic hepatitis B virus (HBV) infection, the Centers for Disease Control and Prevention recommends immunoprophylaxis to decrease perinatal transmission. However, its effectiveness and risk factors for failure have not been well-studied in community practice.
3238. Screening for hepatitis B virus infection in adolescents and adults: a systematic review to update the U.S. Preventive Services Task Force recommendation.
作者: Roger Chou.;Tracy Dana.;Christina Bougatsos.;Ian Blazina.;Jessi Khangura.;Bernadette Zakher.
来源: Ann Intern Med. 2014年161卷1期31-45页
In 2004, the U.S. Preventive Services Task Force (USPSTF) recommended against screening for hepatitis B virus (HBV) infection.
|